Bangor Savings Bank’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$901K Sell
5,752
-419
-7% -$62.8K 0.07% 115
2026
Q1
$943K Sell
6,171
-474
-7% -$72.7K 0.08% 103
2025
Q4
$916K Sell
6,645
-256
-4% -$33.5K 0.07% 111
2025
Q3
$885K Sell
6,901
-677
-9% -$82.6K 0.07% 118
2025
Q2
$917K Buy
7,578
+197
+3% +$22.2K 0.08% 109
2025
Q1
$823K Sell
7,381
-1,097
-13% -$117K 0.08% 117
2024
Q4
$825K Sell
8,478
-20
-0.2% -$2.13K 0.08% 124
2024
Q3
$977K Sell
8,498
-305
-3% -$34.6K 0.09% 112
2024
Q2
$937K Buy
8,803
+206
+2% +$20.7K 0.09% 115
2024
Q1
$832K Sell
8,597
-86
-1% -$8.82K 0.09% 129
2023
Q4
$877K Buy
8,683
+513
+6% +$49.5K 0.1% 118
2023
Q3
$832K Buy
8,170
+247
+3% +$25.1K 0.1% 119
2023
Q2
$800K Buy
7,923
+475
+6% +$47.5K 0.09% 125
2023
Q1
$685K Sell
7,448
-908
-11% -$79.3K 0.08% 131
2022
Q4
$758K Sell
8,356
-2,890
-26% -$243K 0.09% 125
2022
Q3
$855K Buy
11,246
+178
+2% +$14.8K 0.1% 121
2022
Q2
$936K Buy
11,068
+785
+8% +$68.9K 0.1% 121
2022
Q1
$902K Buy
+10,283
New +$890K 0.09% 110
2019
Q4
Sell
-2,437
Closed -$212K 186
2019
Q3
$212K Buy
+2,437
New +$219K 0.04% 176

Other funds holding NVS

Bangor Savings Bank's NVS Position: Q2 2026 in Review

Bangor Savings Bank reduced its Novartis (NVS) stake by 6.8% in Q2 2026, selling an estimated $62.8K and leaving 5,752 shares worth $901K. The position accounts for 0.07% of the portfolio, ranked #115.

Bangor Savings Bank first reported a position in NVS in Q3 2019 and has held it in 19 quarters since. The position peaked at $977K in Q3 2024. 272 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Bangor Savings Bank held 5,752 shares of Novartis worth $901K as of Q2 2026.
  • Bangor Savings Bank sold 419 Novartis shares in Q2 2026, an estimated $62.8K.
  • Novartis made up 0.07% of Bangor Savings Bank's portfolio in Q2 2026, its #115 holding.
  • Bangor Savings Bank first reported a position in Novartis in Q3 2019 and has held it in 19 quarters since.
  • Bangor Savings Bank's Novartis position peaked at $977K in Q3 2024.
  • 272 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Bangor Savings Bank's 13F filing for Q2 2026, filed 6 Jul 2026.